Baxter announced today that it entered into a definitive agreement under which Carlyle Group acquires its Kidney Care business. In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the company to stand alone in the next […]
Carlyle Group
Carlyle Group in talks to buy Baxter’s kidney care spinoff for $4B
Private equity firm Carlyle Group is reportedly in talks to acquire Baxter’s kidney care spinoff, Vantive, for more than $4 billion. The Wall Street Journal reports that Carlyle Group and Baxter entered “exclusive negotiations” in late June to acquire the Vantive spinoff for $4 billion, including debt. Vantive is slated to become a standalone company […]
Report: Private equity firm in negotiations for Medtronic business units
Medtronic and private equity firm Carlyle Group reportedly entered negotiations over two units the medtech giant put on the spinoff block. Nearly a year ago, Medtronic announced its intention to pursue a separation of its Patient Monitoring and Respiratory Interventions businesses. Both are part of the company’s Medical Surgical portfolio. Months later, reports surfaced citing […]
Private equity firms making majority investment in Medline
Medline Industries will stay a privately-held, family-run medtech giant after a majority investment from private equity firms. Blackstone, Carlyle and Hellman & Friedman are making the investment in Medline, which media reports peg at $34 billion. Get the full story on our sister site Medical Design & Outsourcing.
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking outside investors to buy a stake in the healthcare business amid laying off nearly 7,000 workers, wants to focus on its core nuclear energy and chip businesses. Private equity shops KKR and Bain […]
Covidien names Bill Burke as CFO to lead Medtronic merger | The week in medtech M&A
Ex-Boston Scientific finance chief Capello lands at Ortho-Clinical Diagnostics
Johnson & Johnson closes Ortho-Clinical Diagnostics sale
Carlyle officially wins Johnson & Johnson’s diagnostics biz for $4B
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
Madaus is new CEO at Carlyle’s Ortho-Clinical Diagnostics
The Carlyle Group said it tapped Martin Madaus to take over as CEO of the Ortho-Clinical Diagnostics business it’s acquiring from Johnson & Johnson (NYSE:JNJ).
